Hula Therapeutics is a company headquartered in the United States.
Hula Therapeutics is a clinical-stage immunotherapy company that identifies highly specific tumor targets presented via the Human Leukocyte Antigen system and engineers therapies to maximize tumor killing while minimizing healthy tissue toxicity for solid tumors.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.